Durvalumab following chemoradiotherapy improves survival in patients with limited-stage small-ce...
Dr David Spigel speaks to ecancer at ASCO 2024 about the results from ADRIATIC - a study into durvalumab as consolidation treatment for patients with limited-stage small-cell lung cancer.
730 patients were randomised, including 264 to durvalumab and 266 to placebo.
Durvalumab as consolidation treatment after concurrent platinum-based chemoradiotherapy demonstrated a statistically significant and clinically meaningful improvement in overall survival and progression-free survival compared with placebo.
Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php
Видео Durvalumab following chemoradiotherapy improves survival in patients with limited-stage small-ce... канала ecancer
730 patients were randomised, including 264 to durvalumab and 266 to placebo.
Durvalumab as consolidation treatment after concurrent platinum-based chemoradiotherapy demonstrated a statistically significant and clinically meaningful improvement in overall survival and progression-free survival compared with placebo.
Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php
Видео Durvalumab following chemoradiotherapy improves survival in patients with limited-stage small-ce... канала ecancer
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Selective oestrogen receptor degraders as treatment for ER positive/HER2 negative advanced/metas...
Amivantamab combo with lazertinib favourable in post-osimertinib EGFR-mutant NSCLC
An AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validat...
Identifying causing mechanisms in cancers with unknown primary site improves treatment & survival
Regional lymph node irradiation in early breast cancer
Dr. Aizik Wolf -- Cuantas metástasis tratar
Halving duration of ADT for high risk prostate cancer patients
Latest advances in mHSPC from ASCO GU 2020
ESMO 2017: Prostate cancer highlights
Targeting CD70 with cusatuzumab eliminates acute myeloid leukaemia stem cells in humans
Breast cancer highlights from ASCO 2019
Causes, symptoms, and prevention of skin cancer
The CAR T cell revolution in cancer therapy
Phase 3 study shows HER2 therapy clinically meaningful for metastatic breast cancer patients
CLL12 trial: Ibrutinib in previously untreated, asymptomatic early-stage CLL
CLL14: Venetoclax plus obinutuzumab in untreated CLL
Prostate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from...
Managing the side effects of CAR T-cell therapy
LUMINA results: Women with low levels of the Ki67 biomarker can avoid outcomes related to RT
Maintenance chemotherapy extends life for children with rare rhabdomyosarcoma